Cefaclor
Product Images NDC 21695-782

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefaclor (NDC 21695-782). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (9e8890f0 E04a 4555 Ac8d D1b792a5c276 01)

Chemical structure of the active ingredient in CEFACLOR, showing a beta-lactam ring fused to a thiazolidine ring, with a chlorinated carboxylic acid side chain and an adjacent amide-linked phenylglycine moiety, and including a water molecule (H2O) associated with the structure.*

FDA Label Image

Cefaclor 250mg/5ml (9e8890f0 E04a 4555 Ac8d D1b792a5c276 02)

Label for Cefaclor 250 mg per 5 ml oral suspension, 150 ml bottle, distributed by Physician Partner, a division of Rebel Distributors Corp. The label specifies the syrup contains Cefaclor USP monohydrate equivalent to 250 mg anhydrous cefaclor per 5 ml teaspoon, reconstituted with strawberry flavor powder. Manufactured by Ranbaxy Laboratories Ltd, New Delhi, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.